2 ASX healthcare shares rocketing over 16% on Big US news

MotleyFool10-03

There have been some big moves in the healthcare sector on Thursday. For example, the two ASX healthcare shares listed below are up at least 16% in morning trade thanks to big news in the United ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2472638329?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-03 09:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472638329","market":"us","top_or_hot":-1,"title":"2 ASX healthcare shares rocketing over 16% on Big US news","media":"MotleyFool","content":"<div>\n<p>There have been some big moves in the healthcare sector on Thursday.\nFor example, the two ASX healthcare shares listed below are up at least 16% in morning trade thanks to big news in the United ...</p>\n\n<a href=\"https://www.fool.com.au/2024/10/03/2-asx-healthcare-shares-rocketing-over-16-on-big-us-news/\">Source Link</a>\n\n</div>\n","source":"motleyfoolau_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 ASX healthcare shares rocketing over 16% on Big US news</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 ASX healthcare shares rocketing over 16% on Big US news\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-03 09:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com.au/2024/10/03/2-asx-healthcare-shares-rocketing-over-16-on-big-us-news/><strong>MotleyFool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There have been some big moves in the healthcare sector on Thursday.\nFor example, the two ASX healthcare shares listed below are up at least 16% in morning trade thanks to big news in the United ...</p>\n\n<a href=\"https://www.fool.com.au/2024/10/03/2-asx-healthcare-shares-rocketing-over-16-on-big-us-news/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CYC.AU","symbol_name":"CYCLOPHARM LTD","start_time":0,"source_url":"https://www.fool.com.au/2024/10/03/2-asx-healthcare-shares-rocketing-over-16-on-big-us-news/","article_id":"2472638329","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472638329","pubTimestamp":1727917623,"sourceInfo":{"source_id":"motleyfoolau_stock","name":"MotleyFool"},"weMediaInfo":null,"summary":"There have been some big moves in the healthcare sector on Thursday.For example, the two ASX healthcare shares listed below are up at least 16% in morning trade thanks to big news in the United States.The Cyclopharm share price is up 18% to $1.80. Investors have been buying the ASX healthcare share this morning after it announced an interim agreement to supply the Veterans Health Administration  with the pharmaceutical and consumable components of Technegas.This could be a very big deal for Cyclopharm given that the VA is the largest integrated US Government health care system in the United States.According to the release, the interim agreement immediately provides the 120 Veterans Affairs hospitals, which have nuclear medicine departments, access to an agreed contract for these products.The ASX healthcare share's CEO and managing director, Doug Ward, commented,Special mention goes to fellow ASX healthcare share Mesoblast Ltd , which is rising over 9% today. However, with no news out o","collect":0,"end_time":0,"defaultTopTitle":"fool.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"CYC.AU":"CYCLOPHARM LTD","LDX.AU":"LUMOS DIAGNOSTICS HOLDINGS L","BK7501":"新冠治疗股","MSB.AU":"MESOBLAST LTD","BK7007":"医疗保健设备","CLIA":"VERIDIEN CLIMATE ACTION ETF","BK7508":"医药生物股","BK7126":"医疗保健用品","BK7067":"生物科技"},"translate_title":"2 ASX healthcare股价因美国重大新闻飙升超过16%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLIA":1,"CYC.AU":1,"LDX.AU":1,"MSB.AU":1},"content_text":"There have been some big moves in the healthcare sector on Thursday.\nFor example, the two ASX healthcare shares listed below are up at least 16% in morning trade thanks to big news in the United States.\nHere's what you need to know about them:\nCyclopharm Ltd (ASX: CYC)\nThe Cyclopharm share price is up 18% to $1.80. Investors have been buying the ASX healthcare share this morning after it announced an interim agreement to supply the Veterans Health Administration (VA) with the pharmaceutical and consumable components of Technegas.\nTechnegas is the company's core radiopharmaceutical product, used in functional lung ventilation imaging.\nThis could be a very big deal for Cyclopharm given that the VA is the largest integrated US Government health care system in the United States.\nAccording to the release, the interim agreement immediately provides the 120 Veterans Affairs hospitals, which have nuclear medicine departments, access to an agreed contract for these products.\nCyclopharm's CEO, James McBrayer, commented:\n\nSecuring this Interim Agreement is critical for streamlining the United States Federal Government procurement process. This agreement bypasses the need for Cyclopharm to negotiate separate contracts with each of the 20 Regional Procurement Offices within the VA or potentially follow a reseller pathway that would delay the deployment of Technegas, distance us from our customers and impact margins beyond the legislated discounts required for federal contracts.\n\nLumos Diagnostics Holdings Ltd (ASX: LDX)\nThe Lumos Diagnostics share price is up 16% to 4.3 cents.\nThis has been driven by news that the point-of-care diagnostic technology provider has been awarded ~US$3 million from the Biomedical Advanced Research and Development Authority (BARDA). It is part of the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response.\nThese funds are to support the planned Clinical Laboratory Improvement Amendments (CLIA)-waiver clinical study and regulatory submission for Lumos' FebriDx bacterial/non-bacterial test.\nFebriDx can aid clinicians with appropriate antibiotic use decisions and will hopefully improve antibiotic stewardship.\nThe ASX healthcare share's CEO and managing director, Doug Ward, commented,\n\nSince early clinical practice, doctors have relied primarily on clinical observation to determine whether patients require antibiotics for acute respiratory conditions. FebriDx is a powerful diagnostic which can provide a quick and clear clinical evaluation, and in doing so, can reduce over-prescription of antibiotics.\n\nSpecial mention goes to fellow ASX healthcare share Mesoblast Ltd (ASX: MSB), which is rising over 9% today. However, with no news out of the company, it remains unclear why investors are scrambling to buy its shares today.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2472638329"}